Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraarticular Tranexamic Acid in ACL Reconstruction
NCT03580018Completed
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jun 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in hemarthrosis (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Volume of drainage at 24 hours. Started Jun 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemarthrosis
Beyond the preview
Go deeper on NCT03580018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580018.